Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
1:21-cv-01138
Overview
Parties
Defendant
Avadel CNS Pharmaceuticals LLC Operating Company
Represented By
19 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Avadel Management Corporation NPE (Individual / Inventor)
Represented By
8 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Avadel Legacy Pharmaceuticals, LLC Operating Company
Represented By
8 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Avadel Specialty Pharmaceuticals, LLC Operating Company
Represented By
8 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Avadel US Holdings, Inc. NPE (Patent Assertion Entity)
Represented By
8 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Avadel Pharmaceuticals plc NPE (Individual / Inventor)
Represented By
11 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Plaintiff
Jazz Pharmaceuticals Ireland Limited NPE (University / Research)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Jazz Pharmaceuticals, Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 6 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → |
Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.
Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.
Avadel CNS Pharmaceuticals, LLC v. Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC
Patents Involved
There are 5 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10959956
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
Filed: 2020-09-04
Issued: 2021-03-30
|
Active (13.8 yrs remaining)
Expires: 2040-09-04
|
|
|
US8731963
Sensitive drug distribution system and method
|
Filed: 2012-08-22
Issued: 2014-05-20
|
Active (5.8 yrs remaining)
Expires: 2032-08-22
|
|
|
US11077079
GHB formulation and method for its manufacture
|
Filed: 2020-12-10
Issued: 2021-08-03
|
Active (14.1 yrs remaining)
Expires: 2040-12-10
|
|
|
US11147782
GHB formulation and method for its manufacture
|
Filed: 2021-03-23
Issued: 2021-10-19
|
Active (14.3 yrs remaining)
Expires: 2041-03-23
|
|
|
US10966931
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
|
Filed: 2020-09-04
Issued: 2021-04-06
|
Active (13.8 yrs remaining)
Expires: 2040-09-04
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
204
Dispositive
51
Granted
2
Denied
4
Pending / Review
155
Motions by Category
Key Dispositive Motions & Rulings